SafER Medical Products, Inc.
Keep the Disease with the Patient
▼ keep reading ▼
SafER Medical Products, Inc.
Offering Platform
INTRODUCTION TO OUR COMPANY
SafER Medical Products, Inc. began operations with the purpose of developing and producing the SafER respiratory shield, endoshield and Portable Negative Pressure system in order to provide patients and healthcare workers with an innovative defense against airborne contaminants.
The Company has developed the SafER Portable Negative Pressure System, a respiratory medical system designed to capture fugitive particles emitted from patient's exhalation to provide a SafER work environment, such as ambulances, hospitals and doctors' offices. The Device is ideal for medical professionals administering tests, performing exams, and using essential equipment that increases exposure to airborne illnesses and microparticles. The Company plans to establish and promote the Device to healthcare professionals and industry experts.
The Device was created by practicing emergency room doctors who were trying to practice medicine during the COVID Pandemic. It had become clear that respiratory illness was crippling our nation and they got to work to find a solution. The result was more than what they were looking for as it not only helped with the spread of Covid but also with the spread of other airborne illnesses. Their Device quite simply helps to take ALL respiratory pathogens off the table
operations summary
Research on Effectiveness of the Device
Respiratory Shield
CFD Study: A computational fluid dynamics (CFD) study was performed to characterize the performance of a new Respiratory Shield. The study was intended to assess the ability of the Respiratory Shield in removing micron-sized water droplets. The suction, located at the base of the Respiratory Shield, creates an inwards flow of air towards the user which removes over 93% of 0.5 micron sized particles exhaled, 6% is re-inhaled by the patient and 1% remains within the shield. The remaining particles are suspended within the shield or re-inhaled by the user. The study also showed that when the user is given inhaled medications the intended level of medication is still delivered to the user from the nebulizer and ventilation system with this innovative air containment system.
Ambulance and Helicopter Study: This study was performed in the patient area of both helicopter and ambulance platforms, proving the effectiveness of our system. The ambulance study delineated containment of 98% of fugitive particles and the helicopter study delineated containment of 95% of fugitive particles.
Standard Hospital Room vs Negative Pressure Room Study: This study was performed in a hospital type room with negative pressure on and off. With our system on and negative pressure off, our system reduced the particle count by 2 orders of magnitude or 100%. With our system on and the negative pressure on it shows that it increases the capture rate of particles and decreases the spread of particles within the room.
Enhancement Stage
The system is currently used in multiple facilities and EMS agencies. Some professional facilities use it exclusively as part of their respiratory protocol. Across the country, the system is being used on a trial basis and feedback has been overwhelmingly positive, increasing the Company’s ability to enhance product development. The SafER System began with version 1 of the Respiratory Shield and the Endo Shield. With feedback from the medical community, version 2 of the Respiratory Shield and version 2 of the Endo Shield were developed. A smaller and quieter vacuum was also developed. SafER then created a Hospital/IV vacuum and also a hard case vacuum to add to the SafER line. A Trach Shield Prototype has now been developed and several versions of new vacuum systems are awaiting development.
What We Have Accomplished
We were able to bring a medical product to market in record time. We were in a rush to bring the product to the end users as they were in dire need of our system. Along the way we realized our system wasn't fitting all the needs our customers had. We have spent the last year redesigning the system to fit those needs. We have also begun to investigate ways for our system to gain reimbursement.
Industry average is anywhere from 2 to 5 years from proof-of concept to market. We had initial sales of version 1.0 in less than a year. We have done so at a fraction of what it normally costs. The expected cost from proof-of-concept to FDA clearance is $2-5 million for a simple product. Our products are not simple. The vacuum is class II FDA registered and the shields are class I FDA registered.
Our Goals
- Increase inventory to meet demand in a timely manner;
- Pursue Insurance Reimbursement for shield system;
- Establish patents in other countries where product is already being presented;
- Establish sales force to market product; and
- New product design.
Maximum Offering
$10,000,000
Minimum Offering
$100,000
Minimum Investment
$100,000
$10,000,000
Minimum Offering
$100,000
Minimum Investment
$100,000
$100,000
Minimum Investment
$100,000
$100,000
terms of the offering
$10,000,000
Minimum Offering: $100,000
Minimum Investment: $100,000
SafER Medical Products is offering up to $10,000,000 of Class B Common Shares. Shares will be issued at $50 per Share with a minimum subscription of $100,000 per Investor. The Company may accept subscriptions in lesser amounts in its sole discretion.
The voting, dividend and liquidation rights of the holders of the Common Stock are set by the Certificate of Incorporation and Bylaws and the relevant Delaware laws.
Dividends: As approved by the Board of Directors.
Voting: 286,000 Class A voting shares. 714,000 Class B non-voting shares.
Estimated Use of Proceeds
Management Team
The Company is currently managed by seasoned business and sector professionals dedicated to the success of the Company and efficient execution of its planned operations.
Carl Baker
Carl Baker
President, CEO
Carl E. Baker served as a front-line firefighter for 28 years at Central Pierce Fire Department located in Washington State. He was promoted from Lieutenant to Captain and then retired at the rank of Battalion Chief in 2018. Carl served on the Special Operations Technical Rescue Team, the Hazard Materials Team and was in charge of Fire Department Operations for the 6th largest regional fair in the nation during his tenure.
During Carl's career, he owned and operated eleven rental houses ranging from single family to multi units. After retirement, these units were sold, and Carl built three custom Adult Family Homes that he continues to operate today. Each home houses six residents with 24-hour care. This has been a very successful business and has built a reputation as the Best in the County for AFH senior housing.
Carl has held a real estate license for 30 years in the state of Washington. He now holds a legal real estate broker licenses in Washington, Hawaii, Georgia, Louisiana, North Carolina, Florida and Tennessee.
Carl's experience in business and public service leads him to become an integral part of the SafER Team.
Todd Baker, MD
Todd Baker, MD
Vice President, COO
Todd Baker earned his Bachelor's of Science from Quachita Baptist University in 1998 and his Doctorate of Medicine degree from University of Arkansas for Medical Sciences in 2001. He them relocated to Ft Hood for his Emergency Medicine residency, graduating in 2004.
In September of 2007 he joined the 86th Combat Support Hospital for its fifteen-month tour in Iraq. There, Todd served as Chief of Emergency Medicine at Ibn Sina Hospital, “Baghdad ER”, in Baghdad, Iraq. He also served as the Consultant to the Surgeon General for Emergency Medicine in the Iraqi Theater. During his 7 years serving in the Army, he was published in multiple medical journals to include Annals of Emergency Medicine and EM Clinics of North America. He wrote a book based on his time serving overseas, Baghdad ER: 15 Minutes.
Todd serves as Business Affairs Officer for 360 Degree Medicine in addition to being the Medical Director for Taney County Ambulance District.
Todd’s experience in real world emergency medicine and public service leads him to become an integral part of the SafER Team.
G. Matthew Rettig
G. Matthew Rettig
CPA, CFO
G. Matthew Rettig earned a B.A. in Accounting in from The University of Puget Sound and has been a licensed Certified Public Accountant (CPA) since 1998. He has been a Series 65 license holder since 2022.
Matt is a CPA Financial Planner and is the owner of both Alitus Consulting LLC his CPA firm, and Alitus Financial Services his Investment Advisory Practice located in Florida.
Prior to this, he was a partner of what is now modern-day RF Company CPA's PS, a CPA firm specializing in accounting, tax, and business consulting from 2002-2021. Having been a CPA and small business owner for over 20 years, he takes a practical approach to providing unique solutions and added value for his clients and stakeholders.
Matt’s experience in business and finance leads him to become an integral part of the SafER Team.
so much more than what you see
Create an account to review the offering documents for our opportunity. Once registered, you will be able to:
- Access to the Private Placement Memorandum, which outlines our company and gives greater detail about our offering;
- Access to our SEC filing;
- View real time offering metrics of how far along we are in the offering process;
- View a timeline of your progress in the subscription process;
- View company contact information - directly contact us with any questions;
- Easily upgrade your account with the click of a button to go through the subscription process.
When ready to invest, upgrade your account to:
- Complete the subscription documents;
- Upload accreditation documents, if applicable;
- Access instructions on transfer of investment funds;
- Access company documents including Reports, Financials, and Supporting Documents;
- Access the Asset Portfolio, if applicable;
- View News articles written by the company;
- View and download documents associated with your account;
- View distributions to your account, if applicable.